ask="1.65"
ask_size="900"
average_daily_volume="331395"
bid="1.60"
bid_size="400"
book_value="0.34"
change="+0.06"
change_from_200_day_moving_average="-0.04"
change_from_50_day_moving_average="0.03"
change_from_52_week_high="-3.45"
change_From_52_week_low="0.54"
change_in_percent="+3.78%"
close="1.65"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.49"
ebitda="-12.32M"
eps_estimate_current_year="-1.58"
eps_estimate_next_quarter="-0.36"
eps_estimate_next_year="-0.88"
ex_dividend_date="N/A"
float_shares="3761000"
high="1.65"
high_52_weeks="5.10"
last_trade_date="2/9/2017"
last_trade_price="1.65"
last_trade_size="100"
last_trade_time="4:00pm"
low="1.56"
low_52_weeks="1.11"
market_capitalization="15.82M"
moving_average_200_day="1.69"
moving_average_50_day="1.62"
name="Eyegate Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="10.00"
open="1.56"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-2.48%"
percent_change_from_50_day_moving_average="+1.96%"
percent_change_from_52_week_high="-67.65%"
percent_change_from_52_week_low="+48.65%"
previous_close="1.59"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="4.69"
price_per_sales="29.95"
revenue="508889.00"
shares_outstanding="9585000"
short_ratio="2.32"
stock_exchange="NCM"
symbol="EYEG"
volume="87968"
weeks_range_52="1.11 - 5.10"
